14 The trial also showed Donanemab slowed cognitive decline by 35% and showed 39% lower risk of progressing to the next stage of the disease when compared to placebo
The episode explores the science, clinical applications, and real-world considerations surrounding todays most discussed peptide therapies
Yuanyi Peng, [email protected] Specialty section: This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Immunology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Patient awareness gaps drive poor treatment decisions: Limited knowledge that no IV glutathione is FDA-approved for skin lightening Lack of awareness about the 32% adverse event rate including serious complications Aesthetic clinic promotion continues despite regulatory warnings from multiple countries Misconception that higher cost ($2,000-$3,200) equals better results The 2025 Philippine FDA warning states there are no published guidelines for appropriate dosing regimens
Key research themes involving glutathione include: Scavenging of free radicals (e.g., peroxides, nitrogen dioxide, hypochlorous acid) Support of other antioxidant systems (e.g., vitamin C and vitamin E recycling) Detoxification via glutathione S-transferases and related enzymes Regulation of protein folding, disulfide-bond formation, and thiol redox status Modulation of inflammatory mediators, nitric oxide pathways, and cellular metabolism Because endogenous glutathione synthesis capacity appears to decrease with age in many models, glutathione is frequently used as both an experimental variable and a biomarker in studies of aging, disease susceptibility, and redox imbalance
